Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury
0 sources
Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury
Summary
Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury is a doctoral thesis[1].
Key Facts
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury authored Jarred Griffin[2].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's instance of is recorded as doctoral thesis[3].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's publisher is recorded as ResearchSpace@Auckland[4].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's copyright license is recorded as Creative Commons Attribution-NonCommercial-ShareAlike 3.0 New Zealand[5].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's country of origin is recorded as New Zealand[6].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's publication date is recorded as +2018-00-00T00:00:00Z[7].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's main subject is recorded as pharmacology[8].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's work available at URL is recorded as https://researchspace.auckland.ac.nz/handle/2292/41229[9].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's Handle ID is recorded as 2292/41229[10].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's title is recorded as Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury[11].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's copyright holder is recorded as Jarred Griffin[12].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's thesis submitted to is recorded as University of Auckland[13].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's on focus list of Wikimedia project is recorded as NZThesisProject[14].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's copyright status is recorded as copyrighted[15].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's online access status is recorded as open access[16].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's thesis committee member is recorded as Simon O'Carroll[17].
- Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's thesis committee member is recorded as Deborah Young[18].
Body
Designation and Status
Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury's instance of is recorded as doctoral thesis[3].